Instil Bio Inc TIL

Healthcare Biotechnology

Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first such program is an engineered tumor infiltrating lymphocyte (TIL), cell therapy for the treatment of cancer. It is engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor (CoStAR), platform. The Company's lead CoStAR-TIL product candidate, ITIL-306, expresses a CoStAR molecule designed to recognize folate receptor alpha (Fra), a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC and renal cancer. CAR-T and TCR-T therapies are cell products composed of T cells that have been genetically engineered to recognize a specific cancer-related antigen on the surface of tumor cells.

NDAQ:TIL - Post by User

Instil Bio Inc

Bullboard Posts

Comment by joe_trouton Jul 27, 2011 3:58am

513 Views

Post# 18876897

RE: RE: RE: RE: NR - Golden Predator Commences Dri

It's just manipulation and investor apathy. China and India are buying up the gold. Westerners just watch in disbelief and refuse to buy the miners since they probably think gold is in a bubble. Most people around me suffer from "normalcy bias" and the huge deficits, debt, and money printing is not alarming to them. I am going to wait it out until we get through the denial phase. Might take a while because the average person is pretty dense.

Bullboard Posts

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!